Tumor Necrosis Factor-α

CPT: 83520
Updated on 5/28/2019
Print Share

Synonyms

  • Cachectin

Expected Turnaround Time

3 - 7 days

3 - 7 days


Related Documents


Specimen Requirements


Specimen

Serum, frozen


Volume

1 mL


Minimum Volume

0.4 mL (Note: This volume does not allow for repeat testing.)


Container

Red-top tube or gel-barrier tube


Collection

Allow blood sample collected in serum separator tube to clot at room temperature for 30 minutes prior to centrifugation. Allowing samples to sit on the clot for more than 30 minutes may result in higher TNF-alpha levels.

Transfer the serum into a LabCorp PP transpak frozen purple tube with screw cap (LabCorp No. 49482). Freeze immediately and maintain frozen until tested. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested


Storage Instructions

Freeze.


Stability Requirements

Temperature

Period

Frozen

9 days

Freeze/thaw cycles

Stable x2


Causes for Rejection

Nonfrozen specimen; nonserum specimen; gross lipemia; gross hemolysis


Test Details


Limitations

Results of this test are labeled for research purposes only by the assay's manufacturer. The performance characteristics of this assay have not been established by the manufacturer. The result should not be used for treatment or for diagnostic purposes without confirmation of the diagnosis by another medically established diagnostic product or procedure. The performance characteristics were determined by LabCorp.


Methodology

Enzyme-linked immunosorbent assay (ELISA)


Reference Interval

0.0−2.2 pg/mL


Additional Information

Tumor necrosis factor-α (cachectin) and tumor necrosis factor-β (lymphotoxin) are two closely related proteins that share sequence homology of 34% in their amino acid sequence. Both mediators act on their target cells via the same receptors and, therefore, show similar, but not identical, biological effects. Under denaturing conditions TNF-α is a 17-kilodalton, nonglycosylated protein. The biologically active form of TNF-α is a trimer. Besides this soluble form of TNF-α, a 28-kilodalton membrane-bound form occurs on cell surfaces of TNF-producing cells, which may serve as a pool for soluble TNF-α and can be proteolytically cleaved from the cell surface.

Different cells are shown to produce TNF-α: For example, macrophages, CD4+ T cells and NK cells after stimulation with lipopolysaccharides. Additionally, smooth muscle cells, polymorphonuclear neutrophils, astrocytes and a variety of tumor cell lines can produce TNF-α. TNF-α acts via two distinct cell surface receptors, which are called TNF receptor I, and TNF receptor II. These receptors can be identified on virtually all cell types except erythrocytes. Besides the cell-bound forms of TNF receptors, soluble forms are known to be capable of TNF-α binding. They compete, therefore, with the cell-bound forms and can inhibit the effects of TNF-α.

Due to the occurrence of TNF-α receptors on nearly all cells, TNF-α demonstrates a wide variety of biological action. It has cytolytic and cytostatic effects on tumor cells and shows chemotactic activity on neutrophils. TNF-α is a growth factor for fibroblasts and stimulates the synthesis of collagenase and prostaglandin E2 bone resorption can be induced by TNF-α because it activates osteoclasts. TNF-α enhances the proliferation of T cells after stimulation with IL-2. In the absence of IL-2, TNF-α induces the proliferation and differentiation of β cells.

TNF-α serum or plasma levels may be elevated in sepsis, autoimmune diseases, various infectious diseases, and transplant rejection.


References

Buck C, Gallati H, Pohlandt F, et al. Increased levels of tumor necrosis factor alpha (TNF-alpha) in tracheal aspirates of newborns with pneumonia. Infection. 1994; 22(4):238-241. 8002082
Herbelin A, Nguyen AT, Zingraff J, et al. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990; 37(1):116-125. 2299797
Jacob CO. Tumor necrosis factor alpha in autoimmunity: Pretty girl or old witch? Immunol Today. 1992; 13(4):122-125 (review). 1580993
Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 1990; 170(1):32-38. 2294627
Maury CP, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med. 1987; 166(4):1132-1137.3309124

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
140673 Tumor Necrosis Factor-Alpha 3074-2 140682 Tumor Necrosis Factor-Alpha pg/mL 3074-2

For Providers

Please login to order a test.

 

© 2019  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf